Dr. Nicholas Seyfried presented at the first Synuclein Biomarkers & Neuropathology Summit that was featured by Alzforum “Synuclein Summit Rallies Researchers to Better Pathology Detection”. The summit’s “aim was to bring everyone together to openly discuss what is and isn’t working” for Parkinson’s disease. A preprint of the work presented can be found on bioRxiv “Multiplex Proteomics of Lewy Body Dementia Reveals Cerebrospinal Fluid Biomarkers of Disease Pathology and Progression.”
Dr. Nicholas Seyfried was among the few researchers asked to speak at the first Synuclein Biomarkers & Neuropathology Summit to present his team’s analysis of samples from the Parkinson’s Disease Biomarkers Program (PDBP)
